Updates are available Correction dated 2021-12-16

Article History

Received: 7 December 2020

Accepted: 31 March 2021

First Online: 20 April 2021

Change Date: 16 December 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s10877-021-00791-0

Declarations

:

: INdK, MP and JJV have no conflict of interest to declare. ARA is an editor of the British Journal of Anaesthesia. He reports reimbursement for consultancy work and paid phase 1 research by The Medicines Company (Parsippany, NJ, USA) and Rigel Inc (San Francisco, CA); unrestricted research funding and reimbursenment for consultancy work from Carefusion (BD; Eysins, Switzerland) and Philips (Eindhoven, The Netherlands); receipt of consultancy fees from Janssen Pharma (Johnson and Johnson; Beerse, Belgium), Ever Pharma (Unterach am Attersee, Austria), PAION (Aachen, Germany) and Orion (Espoo, Finland). All payments made to institution. MAM received grants from AtriCure (Mason, Ohio, USA), Abbott Laboratories (Chicago, Illinois, USA), Edwards Lifesciences (Irvine, California, USA), Getinge Consultancy (Göteborg, Sweden), LivaNova PLC (London, United Kingdom) and Medtronic (Dublin, Ireland). TWLS received research grants and honoraria from Edwards Lifesciences (Irvine, CA, USA) and Masimo Inc. (Irvine, CA, USA) for consulting and lecturing and from Pulsion Medical Systems SE (Feldkirchen, Germany) for lecturing. TWLS is Editor-in-Chief of the Journal of Clinical Monitoring and Computing but had no role in the handling of this manuscript.

: Ethical approval (Reference: METc2011/045) was obtained from the institutional ethical committee, Groningen, The Netherlands. The study was registered at ClinicalTrials.gov (NCT01347827).

: Informed consent was obtained from all individual participants included in the study.